Literature DB >> 21210079

Understanding glycemic control in the critically ill: three domains are better than one.

James S Krinsley.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 21210079     DOI: 10.1007/s00134-010-2110-3

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  22 in total

1.  Variability of blood glucose concentration and short-term mortality in critically ill patients.

Authors:  Moritoki Egi; Rinaldo Bellomo; Edward Stachowski; Craig J French; Graeme Hart
Journal:  Anesthesiology       Date:  2006-08       Impact factor: 7.892

2.  Blood glucose concentration and outcome of critical illness: the impact of diabetes.

Authors:  Moritoki Egi; Rinaldo Bellomo; Edward Stachowski; Craig J French; Graeme K Hart; Colin Hegarty; Michael Bailey
Journal:  Crit Care Med       Date:  2008-08       Impact factor: 7.598

3.  Diabetes mellitus does not adversely affect outcomes from a critical illness.

Authors:  Brian B Graham; Angela Keniston; Ognjen Gajic; Cesar A Trillo Alvarez; Sofia Medvedev; Ivor S Douglas
Journal:  Crit Care Med       Date:  2010-01       Impact factor: 7.598

4.  Glucose variability and mortality in patients with sepsis.

Authors:  Naeem A Ali; James M O'Brien; Kathleen Dungan; Gary Phillips; Clay B Marsh; Stanley Lemeshow; Alfred F Connors; Jean-Charles Preiser
Journal:  Crit Care Med       Date:  2008-08       Impact factor: 7.598

5.  Glycemic control, diabetic status, and mortality in a heterogeneous population of critically ill patients before and during the era of intensive glycemic management: six and one-half years experience at a university-affiliated community hospital.

Authors:  James S Krinsley
Journal:  Semin Thorac Cardiovasc Surg       Date:  2006

Review 6.  Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.

Authors:  R Phillip Dellinger; Jean M Carlet; Henry Masur; Herwig Gerlach; Thierry Calandra; Jonathan Cohen; Juan Gea-Banacloche; Didier Keh; John C Marshall; Margaret M Parker; Graham Ramsay; Janice L Zimmerman; Jean-Louis Vincent; Mitchell M Levy
Journal:  Crit Care Med       Date:  2004-03       Impact factor: 7.598

7.  Effect of an intensive glucose management protocol on the mortality of critically ill adult patients.

Authors:  James Stephen Krinsley
Journal:  Mayo Clin Proc       Date:  2004-08       Impact factor: 7.616

8.  Intensive insulin therapy and pentastarch resuscitation in severe sepsis.

Authors:  Frank M Brunkhorst; Christoph Engel; Frank Bloos; Andreas Meier-Hellmann; Max Ragaller; Norbert Weiler; Onnen Moerer; Matthias Gruendling; Michael Oppert; Stefan Grond; Derk Olthoff; Ulrich Jaschinski; Stefan John; Rolf Rossaint; Tobias Welte; Martin Schaefer; Peter Kern; Evelyn Kuhnt; Michael Kiehntopf; Christiane Hartog; Charles Natanson; Markus Loeffler; Konrad Reinhart
Journal:  N Engl J Med       Date:  2008-01-10       Impact factor: 91.245

9.  Glucose variability is associated with intensive care unit mortality.

Authors:  Jeroen Hermanides; Titia M Vriesendorp; Robert J Bosman; Durk F Zandstra; Joost B Hoekstra; J Hans Devries
Journal:  Crit Care Med       Date:  2010-03       Impact factor: 7.598

10.  The impact of early hypoglycemia and blood glucose variability on outcome in critical illness.

Authors:  Sean M Bagshaw; Rinaldo Bellomo; Michael J Jacka; Moritoki Egi; Graeme K Hart; Carol George
Journal:  Crit Care       Date:  2009-06-17       Impact factor: 9.097

View more
  7 in total

1.  Association of hyperglycemia, glucocorticoids, and insulin use with morbidity and mortality in the pediatric intensive care unit.

Authors:  Kupper A Wintergerst; Michael B Foster; Janice E Sullivan; Charles R Woods
Journal:  J Diabetes Sci Technol       Date:  2012-01-01

Review 2.  Glycemic variability in hospitalized patients: choosing metrics while awaiting the evidence.

Authors:  Susan S Braithwaite
Journal:  Curr Diab Rep       Date:  2013-02       Impact factor: 4.810

3.  Year in review in Intensive Care Medicine 2011: I. Nephrology, epidemiology, nutrition and therapeutics, neurology, ethical and legal issues, experimentals.

Authors:  Massimo Antonelli; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; J Randall Curtis; Daniel De Backer; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Patricia Rocco; Jean-François Timsit; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2012-01-04       Impact factor: 17.440

Review 4.  Year in review 2013: Critical Care--metabolism.

Authors:  Olivier Lheureux; Jean-Charles Preiser
Journal:  Crit Care       Date:  2014-10-27       Impact factor: 9.097

5.  Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial.

Authors:  Lalantha Leelarathna; Shane W English; Hood Thabit; Karen Caldwell; Janet M Allen; Kavita Kumareswaran; Malgorzata E Wilinska; Marianna Nodale; Jasdip Mangat; Mark L Evans; Rowan Burnstein; Roman Hovorka
Journal:  Crit Care       Date:  2013-07-24       Impact factor: 9.097

6.  Software-guided versus nurse-directed blood glucose control in critically ill patients: the LOGIC-2 multicenter randomized controlled clinical trial.

Authors:  Jasperina Dubois; Tom Van Herpe; Roosmarijn T van Hooijdonk; Ruben Wouters; Domien Coart; Pieter Wouters; Aimé Van Assche; Guy Veraghtert; Bart De Moor; Joost Wauters; Alexander Wilmer; Marcus J Schultz; Greet Van den Berghe; Dieter Mesotten
Journal:  Crit Care       Date:  2017-08-14       Impact factor: 9.097

7.  Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: an international multicenter cohort study.

Authors:  James S Krinsley; Moritoki Egi; Alex Kiss; Amin N Devendra; Philipp Schuetz; Paula M Maurer; Marcus J Schultz; Roosmarijn T M van Hooijdonk; Morita Kiyoshi; Iain M J Mackenzie; Djillali Annane; Peter Stow; Stanley A Nasraway; Sharon Holewinski; Ulrike Holzinger; Jean-Charles Preiser; Jean-Louis Vincent; Rinaldo Bellomo
Journal:  Crit Care       Date:  2013-03-01       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.